Clinical Trial Update: MemFlex to Prevent Depressive Relapse [Phase 2]

View source ↗

Summary

Phase 2 trial update for MemFlex aimed at preventing depressive relapse in adults with major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• MemFlex

Snippet

Sponsor: Medical Research Council Cognition and Brain Sciences Unit | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED